All studies
Ongoing, recruitingTherapeutic exploratory (Phase II)Interventional
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
At a glance
Status
Ongoing, recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
Janssen - Cilag International
Enrolment target
118
Start
17 Jul 2023
What is this study about?
Change in square root GA lesion area in the study eye measured on fundus autofluorescence (FAF)
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (11)
- —Netherlands
- —Belgium
- —Germany
- —Italy
- —Portugal
- —Sweden
- —Hungary
- —Poland
- —Denmark
- —Czechia
- —Spain
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.